Nitric oxide production and MDR expression by human brain endothelial cells

Anticancer Research

Volumn 18, Issue 4 C, 1998, Pages 3049-3052

  Mándi, Yvette ^a   Ocsovszki, Imre ^a   Szabo, Diana ^a   Nagy, Zsuzsanna ^a   Nelson, Jay ^b   Molnar, Joseph ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Endothelial cells; Multidrug resistance; Nitric oxide; TNF

Indexed keywords

GLYCOPROTEIN P; NITRIC OXIDE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN CELL; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BLOTTING, WESTERN; BRAIN; DRUG RESISTANCE, MULTIPLE; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; P-GLYCOPROTEIN; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031867354     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jette L, Pouliot JF, Murphy GF, Beliveau R: Isoform I (mdr3) is the major form of P-glycoproteinexpressed in mouse brain capillaries. Biochem J 305: 761-766, 1995.
2. Abraham Cs, Deli M, Joo F, Megyeri P, Torpier G: Intracarotid tumor necrosis factor administration increases the blood brain barrier permeability in cerebral cortex. of the newbom pig. Neurosci Lett 208: 85-88, 1996.
3. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
4. Tracey WR, The J, Carter G: Lipopolysacharide induced changes in plasma nitrite and nitrateconcentrations in rats and mice, pharmacological evaluation of nitric oxide synthase inhibitors. J Pharm Exp Ther 272: 1011-1015, 1995.
5. Doherty GM, Jensen JC, Alexander HR, Buersh, CM, Norton JA: Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110: 193-198, 1991.
6. Molnar J, Hever A, Fakla I, Fischer J, Ocsovszki I, Aszalós A: Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E.coli and multidrug resistant tumor cells. Anticancer Res 17: 481-486, 1997.
7. Roninson IB: The role of the mdrl (P-glycoprotein) gene in multidrug resistance in vivo and in vitro Biochem. Pharmacol 43: 95-102, 1992.
8. Nooter K, Stoter G: Molecular mechanisms of multidrug resistance in cancer chemotherapy. Path Res Pract 192: 768-780, 1996.
9. Tsuruo T: Biochemical function of P-glycoprotein and implication for therapy. In: The mechanism and New Approach of Drug Resistance in Cancer Cells. Eds Miyazaki T, Takau F. Sakurada. Elsevier, p 81-91. 1993.
10. Murata J, Betz Corradin S, Janzer RC, Jeanneret L: Tumor cell suppresscytokine induced nitric oxide (NO) production in cerebral endothelial cells. Int J Cancer 59: 699-705, 1994.